Skip to main content

St. Jude at AACR 2026

Visit us at booth 2346

 
 

Thank you for visiting St. Jude Children’s Research Hospital at AACR 2026!

By driving breakthroughs at the bench, training the next generation, treating some of the toughest cases, and leading the most clinical trials for childhood cancer, St. Jude is more than a hospital. We’re setting the standard for the way the world treats catastrophic pediatric diseases.

Learn more about the profound impact of our research enterprise and how our collaborative, patient-focused approach is transforming the future of cancer research.

 
 

St. Jude Comprehensive Cancer Center

Woman working in lab

The mission of the St. Jude Comprehensive Cancer Center, which recently received its third consecutive “Exceptional” rating from the National Cancer Institute, is to advance cures for pediatric cancer through research and treatment. We are the nation’s only NCI-designated Cancer Center dedicated exclusively to pediatric cancer.

Our designation as a Comprehensive Cancer Center reflects excellence in laboratory, clinical and survivorship research, as well as leadership in education and community outreach.

The Center aims to improve outcomes and understanding of pediatric cancer to benefit patients and survivors in our catchment area, and to extend these findings to the nation and the world.

Learn more

 
 

St. Jude at AACR 2026

  1. Melissa Hudson

    Melissa Hudson, MD
    Member; Director, Cancer Survivorship Division; Associate Director, Population Sciences, Cancer Survivorship

    Prevalence and factors underpinning multimorbidity after childhood cancer

    Friday, April 17, 4-4:20 PM, [Room 28 – Upper Level]

     
     

    Stephen Gottschalk

    Stephen Gottschalk, MD
    Member; Chair, Department of Bone Marrow Transplantation & Cellular Therapy
    Gottschalk Lab | Bone Marrow Transplantation and Cellular Therapy

    CART Therapy: Transforming the Landscape of Adult and Pediatric Blood Cancers

    Saturday, April 18, 8-9:30 AM, [Ballroom 6 CF – Upper Level]

     
     

    Jinghui Zhang

    Jinghui Zhang, PhD
    Member
    Zhang Lab | Computational Biology

    Therapy related mutagenesis in long term survivors

    Sunday, April 19, 1:05-1:25 PM, [Room 16 - Mezzanine Level] 

     
     

    Lily Guenther

    Lily Guenther, MD
    Assistant Member
    Guenther Lab | Oncology

    Interface of radiation science and pediatric oncology

    Sunday, April 19, 6:30-7:14 PM, [Room 33 - Upper Level]

     
     

    Beth Fox

    Beth Fox, MD, MS
    Member; Senior Vice President, Clinical Trials Research

    Targeting tomorrow: ADCs and novel small molecules in clinical development for children with cancer

    Monday, April 20, 12:31-12:51 PM, [Room 33 – Upper Level]

     
     

     
     

    Brenda Weigel

    Brenda Weigel, MD
    Member; Vice President, Clinical Research Industry Engagement

    Advancing Early-Phase Pediatric Cancer Trials to Turn Promising Agents into Actionable Evidence

    Monday, April 20, 2:50-3:05 PM, [Room 1 – Upper Level]

     
     

    Babis Kalodimos

    Charalampos Kalodimos, PhD
    Member; Chair, Structural Biology
    Kalodimos Lab | Structural Biology

    Structural insights to cancer biology and therapy

    Tuesday, April 21, 10:15-11:30 AM, [Room 28 – Upper Level]

     
     

    Charles WM Roberts MD

    Charles W.M. Roberts, MD, PhD
    Member; Executive Vice President; Director, Comprehensive Cancer Center
    Roberts Lab | Oncology

    Chromatin, Epigenetics & Cancer

    Tuesday, April 21, 10:15-11:30 AM, [Ballroom 6 DE – Upper Level]

     
     

    Renato Umeton

    Renato Umeton, PhD
    Vice President of Data Sciences and Chief of Artificial Intelligence, Office of Data Science

    Agentic AI as the Oncologist

    Wednesday, April 22, 10:15-11:30 AM, [Ballroom 6B – Upper Level]

     
     
  2. Yunchao Chang, PhD
    Scientist | Pathology

    Identification of a potent and selective PPIL4 degrader with therapeutic potential from a library of Cereblon modulators

    Sunday, April 19, 2–5 PM, [Section 51, Poster No. 20]


    Pandurang Kolekar

    Lead Computational Research Scientist | Computational Biology

    Sensitive detection of MYCN amplified neuroblastoma in blood samples with structural variants using standard whole genome sequencing

    Sunday, April 19, 2–5 PM, [Section 50, Poster No. 16]


    Hayden Malone

    Biomedical Sciences PhD Student | Oncology and St. Jude Graduate School of Biomedical Sciences

    PHIP suppresses NuRD to enable the growth of SWI/SNF-mutant cancers

    Sunday, April 19, 2–5 PM, [Section 55, Poster No. 1]


    Neshat Masud, PhD

    Scientist – Quality Control | Good Manufacturing Practices (GMP) Facility

    Development of RT-dPCR-based functional release assays for the RPS19 gene therapy for Diamond-Blackfan anemia

    Sunday, April 19, 2–5 PM, [Section 45, Poster No. 21]


    Janeala Morsby, PhD

    Postdoctoral Research Associate | Oncology

    Synergistic inhibition of PARP and ATM leads to unresolved DNA damage and cohesin-mediated collapse in pediatric osteosarcoma

    Sunday, April 19, 2–5 PM, [Section 49, Poster No. 2]


    Noha Shendy, PhD

    Postdoctoral Research Associate | Oncology

    A genome derived non coding reporter of dynamic cancer cell state

    Sunday, April 19, 2–5 PM, [Section 16, Poster No. 18]


    Bradley Stevens

    Biomedical Sciences PhD Student | Oncology and St. Jude Graduate School of Biomedical Sciences

    Elucidation of PAX3::FOXO1 tumor initiation mechanisms in human induced pluripotent stem cell models

    Sunday, April 19, 2–5 PM, [Section 26, Poster No. 9]


    Samantha Turk

    Biomedical Sciences PhD Student | Developmental Neurobiology and St. Jude Graduate School of Biomedical Sciences

    Novel reporter tool for visualization of neuroblastoma cell state

    Sunday, April 19, 2–5 PM, [Section 28, Poster No. 14]


    Kohei Hagiwara, PhD

    Lead Computational Research Scientist | Computational Biology

    Assessing allelic expression variation using somatic mutations vs. polymorphic germline variants

    Monday, April 20, 9 AM–12 PM, [Section 6, Poster No. 13]


    Su Hyun Lee, PhD

    Postdoctoral Research Associate | Oncology

    Mitochondrial dysfunction induces asparaginase resistance in R-spondin fusion colorectal cancer

    Monday, April 20, 9 AM–12 PM, [Section 16, Poster No. 20]


    Grace McKay-Corkum, MD

    Pediatric Hematology/Oncology Fellow | Pediatric Hematology-Oncology Fellowship Program

    Exome-scale CRISPR screening reveals master controllers of cell state maintenance in high-risk neuroblastoma

    Monday, April 20, 9 AM–12 PM, [Section 16, Poster No. 2]


    Brian Abraham, PhD

    Assistant Member
    Abraham Lab | Computational Biology

    Synergistic targeting of EP300/CBP and EYA co-activators collapses the rhabdomyosarcoma core regulatory circuit

    Monday, April 20, 2–5 PM, [Section 31, Poster No. 15]


    Srijan Acharya, PhD

    Postdoctoral Research Associate | Pharmacy & Pharmaceutical Sciences

    Mithramycin analogues trap the EWS-FLI1 transcriptional complex, evict ETV6, and disable oncogenic condensate function in Ewing sarcoma

    Monday, April 20, 2–5 PM, [Section 31, Poster No. 19]


    Yun-Cheol Chae, PhD

    Scientist | Oncology

    Synthetic lethality of G6PD deficiency and asparaginase for colorectal cancer therapy

    Monday, April 20, 2–5 PM, [Section 11, Poster No. 4]


    Robert Greenhalgh, PhD

    Sr. Computational Research Scientist | Computational Biology

    Structural variation shapes clonal evolution in pediatric cancer

    Monday, April 20, 2–5 PM, [Section 33, Poster No. 1]


    Yoonji Kim, PhD

    Postdoctoral Research Associate | Epidemiology and Cancer Control

    DNA methylation signatures of diet quality and treatment-related cardiotoxicity in childhood cancer survivors

    Monday, April 20, 2–5 PM, [Section 31, Poster No. 20]


    Mohammad Ali Mohammad Nezhady, PhD

    Postdoctoral Research Associate | Oncology

    ATRX in-frame fusions promote endogenous chemoresistance programs but yield immunotherapeutic vulnerabilities in neuroblastoma

    Monday, April 20, 2–5 PM, [Section 13, Poster No. 17]


    Stephanie Sandor, PhD

    Sr. Research Program Manager | St. Jude Cloud

    Advancing pediatric tumor subtype classification on the pediatric cancer (PeCan) knowledge base by integrating molecular and morphology data

    Monday, April 20, 2–5 PM, [Section 31, Poster No. 3]


    Daniel Savic, PhD

    Associate Member
    Savic Lab | Pharmacy and Pharmaceutical Sciences

    Integrative multi-omic investigation of gene regulatory networks associated with chemotherapy response in acute lymphoblastic leukemia

    Monday, April 20, 2–5 PM, [Section 17, Poster No. 22]


    Nadezhda Terekhanova, PhD

    Principal Computational Research Scientist | Computational Biology

    T-cell transcriptome affected by therapy-related clonal hematopoiesis in long-term survivors of pediatric cancers

    Tuesday, April 21, 9 AM–12 PM, [Section 41, Poster No. 4]


    Declan Bennett, PhD

    Postdoctoral Research Associate | Computational Biology

    An ensemble machine learning approach to ALT detection revals therapeutic vulnerabilities in pediatric cancers lacking actionable drug targets

    Tuesday, April 21, 2–5 PM, [Section 4, Poster No. 11]


    Lisett Contreras, PhD

    Postdoctoral Research Associate | Pathology

    The in vivo impact of UBTF tandem duplications on hematopoiesis and leukemia development

    Tuesday, April 21, 2–5 PM, [Section 26, Poster No. 10]


    Limeng Pu, PhD

    Sr. Computational Research Scientist | Computational Biology

    MethylFM: A DNA methylation foundation model for modeling epigenomic regulatory dynamics

    Tuesday, April 21, 2–5 PM, [Section 2, Poster No. 18]


    Ruth Wang’ondu, MD, PhD

    Instructor
    Wang'ondu's Research | Oncology

    The IKZF1 N159Y partial tandem duplication mutant drives chromatin remodeling, B-cell developmental defects and leukemia initiation

    Tuesday, April 21, 2–5 PM, [Section 26, Poster No. 3]


    Jake Friske

    Biomedical Sciences PhD Student | St. Jude Graduate School of Biomedical Sciences

    A conserved enhancer locus in ecDNA and HSRs activates MYC transcription in group 3 medulloblastoma

    Wednesday, April 22, 9 AM–12 PM, [Section 54, Poster No. 12]


    Elizabeth Stewart, MD

    Associate Member
    Stewart Lab | Oncology, Developmental Neurobiology

    Efficacy of ABBV-706, a SEZ6-targeted topoisomerase 1 inhibitor ADC: A report from the Pediatric Preclinical In Vivo Testing (PIVOT) Program

    Wednesday, April 22, 9 AM–12 PM, [Section 44, Poster No. 18]

 
 

St. Jude Postdoctoral Fellowships

two women in a lab

St. Jude Children’s Research Hospital offers postdoctoral fellows a unique blend of academic freedom and industrial efficiency, empowering them to accelerate discoveries with cutting-edge technology and expert-led resources. Fellows join a vibrant, collaborative community driven by a shared mission to advance cures for catastrophic childhood diseases worldwide. St. Jude invests in its postdocs with competitive pay, comprehensive benefits, and tailored professional development programs. Here, your research has global impact—and your growth is a priority.

Explore opportunities

 

St. Jude Graduate School of Biomedical Sciences

Guy listening in class

The St. Jude Graduate School of Biomedical Sciences offers students a personalized, high-impact education led by world-renowned faculty and small cohorts, fostering individual growth and lasting mentorship. Students thrive in an environment that values balance, wellness, and support, while engaging in immersive, hands-on training in cutting-edge labs and clinical spaces. With full tuition support, a competitive stipend, and comprehensive benefits, students can focus fully on their development and future success. Join a mission-driven community advancing cures for pediatric catastrophic diseases and shaping the future of science and medicine.

Find your future

 

St. Jude Careers

St. Jude campus

At St. Jude Children’s Research Hospital, we’re redefining what’s possible in science and medicine. Our teams collaborate across disciplines to advance groundbreaking research that saves lives and shapes the future of pediatric care. A career at St. Jude offers the opportunity to work with world-class experts, access cutting-edge resources, and make a global impact. Join us and help lead discoveries that change lives—because at St. Jude, every child deserves a chance.

See openings

 

St. Jude Internships

people working in a lab

An internship at St. Jude Children's Research Hospital gives you a unique training experience while helping children with cancer and other life-threatening diseases. St. Jude offers internships, externships and other short-term training opportunities in areas as diverse as the hospital itself: from patient care and scientific research, to volunteer services, law and information technology.

Explore available internships

 
 
 

Get to know the community, city life and distinctive culture that makes Memphis so special.

 
 
 
Close